3.22.4 html 48 96 1 false 11 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://peakpharma.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://peakpharma.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://peakpharma.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://peakpharma.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) Sheet http://peakpharma.com/role/ConsolidatedStatementsOfOperationsParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (EQUITY) (Unaudited) Sheet http://peakpharma.com/role/ConsolidatedStatementOfStockholdersDeficitEquity CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (EQUITY) (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://peakpharma.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://peakpharma.com/role/NatureOfOperationsBasisOfPresentationAndSummaryOfSignificantAccountingPolicies NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN AND MANAGEMENT???S LIQUIDITY PLANS Sheet http://peakpharma.com/role/GoingConcernAndManagementsLiquidityPlans GOING CONCERN AND MANAGEMENT???S LIQUIDITY PLANS Notes 9 false false R10.htm 00000010 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://peakpharma.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 10 false false R11.htm 00000011 - Disclosure - CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE Notes http://peakpharma.com/role/ConvertibleNotesPayableAndNotesPayable CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE Notes 11 false false R12.htm 00000012 - Disclosure - OPTIONS Sheet http://peakpharma.com/role/Options OPTIONS Notes 12 false false R13.htm 00000013 - Disclosure - SUBSEQUENT EVENTS Sheet http://peakpharma.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 13 false false R14.htm 00000014 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://peakpharma.com/role/NatureOfOperationsBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 14 false false R15.htm 00000015 - Disclosure - OPTIONS (Tables) Sheet http://peakpharma.com/role/OptionsTables OPTIONS (Tables) Tables http://peakpharma.com/role/Options 15 false false R16.htm 00000016 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://peakpharma.com/role/NatureOfOperationsBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://peakpharma.com/role/NatureOfOperationsBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies 16 false false R17.htm 00000017 - Disclosure - GOING CONCERN AND MANAGEMENT???S LIQUIDITY PLANS (Details Narrative) Sheet http://peakpharma.com/role/GoingConcernAndManagementsLiquidityPlansDetailsNarrative GOING CONCERN AND MANAGEMENT???S LIQUIDITY PLANS (Details Narrative) Details http://peakpharma.com/role/GoingConcernAndManagementsLiquidityPlans 17 false false R18.htm 00000018 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://peakpharma.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://peakpharma.com/role/RelatedPartyTransactions 18 false false R19.htm 00000019 - Disclosure - CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE (Details Narrative) Notes http://peakpharma.com/role/ConvertibleNotesPayableAndNotesPayableDetailsNarrative CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE (Details Narrative) Details http://peakpharma.com/role/ConvertibleNotesPayableAndNotesPayable 19 false false R20.htm 00000020 - Disclosure - STOCK OPTIONS (Details) Sheet http://peakpharma.com/role/StockOptionsDetails STOCK OPTIONS (Details) Details 20 false false R21.htm 00000021 - Disclosure - STOCK OPTIONS (Details 2) Sheet http://peakpharma.com/role/StockOptionsDetails2 STOCK OPTIONS (Details 2) Details 21 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 8 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 - pkph123122-10q.htm 42, 43, 44, 45, 46, 47, 48, 49 pkph123122-10q.htm pkph-20221231.xsd pkph-20221231_cal.xml pkph-20221231_def.xml pkph-20221231_lab.xml pkph-20221231_pre.xml pkph123122-ex31_1.htm pkph123122-ex31_2.htm pkph123122-ex32_1.htm pkph123122-ex32_2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true